Cargando…

Signalome-wide assessment of host cell response to hepatitis C virus

Host cell signalling during infection with intracellular pathogens remains poorly understood. Here we report on the use of antibody microarray technology to detect variations in the expression levels and phosphorylation status of host cell signalling proteins during hepatitis C virus (HCV) replicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haqshenas, Gholamreza, Wu, Jianmin, Simpson, Kaylene J., Daly, Roger J., Netter, Hans J., Baumert, Thomas F., Doerig, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424167/ https://www.ncbi.nlm.nih.gov/pubmed/28480889 http://dx.doi.org/10.1038/ncomms15158

Ejemplares similares

Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens
por: John von Freyend, Simona, et al.
Publicado: (2017)

Repurposing of a human antibody-based microarray to explore conserved components of the signalome of the parasitic nematode Haemonchus contortus
por: Adderley, Jack, et al.
Publicado: (2022)

COVID-19 signalome: Potential therapeutic interventions
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

The effects of mutant Ras proteins on the cell signalome
por: Takács, Tamás, et al.
Publicado: (2020)

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
por: Martin, Daniel, et al.
Publicado: (2018)

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms
por: KayvanJoo, Amir Hossein, et al.
Publicado: (2014)

The emerging Pannexin 1 signalome: a new nexus revealed?
por: Wicki-Stordeur, Leigh E., et al.
Publicado: (2014)

Signalome-wide RNAi screen identifies GBA1 as a positive mediator of autophagic cell death
por: Dasari, Santosh K, et al.
Publicado: (2017)

Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets
por: Atanes, Patricio, et al.
Publicado: (2018)

Exploring the xylose paradox in Saccharomyces cerevisiae through in vivo sugar signalomics of targeted deletants
por: Osiro, Karen O., et al.
Publicado: (2019)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
por: Aliper, Alexander, et al.
Publicado: (2016)

A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro
por: Haqshenas, G., et al.
Publicado: (2007)

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)
por: Negm, Ola H, et al.
Publicado: (2014)

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
por: Netter, Hans J., et al.
Publicado: (2021)

PAK in pathogen-host interactions
por: Semblat, Jean-Philippe, et al.
Publicado: (2012)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Boceprevir and personalized medicine in hepatitis C virus infection
por: Habersetzer, François, et al.
Publicado: (2012)

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

New perspectives for preventing hepatitis C virus liver graft infection
por: Felmlee, Daniel J., et al.
Publicado: (2016)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

Genome-wide functional genomic and transcriptomic analyses for genes regulating sensitivity to vorinostat
por: Falkenberg, Katrina J, et al.
Publicado: (2014)

Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection†
por: Crouchet, E., et al.
Publicado: (2017)

Comparative analysis of the kinomes of Plasmodium falciparum, Plasmodium vivax and their host Homo sapiens
por: Adderley, Jack, et al.
Publicado: (2022)

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
por: Fafi-Kremer, Samira, et al.
Publicado: (2012)

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease
por: Felmlee, Daniel J., et al.
Publicado: (2013)

The Impact of Host Factors on Management of Hepatitis C Virus
por: Khattab, Mahmoud Aboelneen, et al.
Publicado: (2012)

Transmissibility of intra-host hepatitis C virus variants
por: Campo, David S., et al.
Publicado: (2017)

Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism
por: Sugawara, Sho, et al.
Publicado: (2023)

Hepatitis C Virus and Vaccine Development
por: Naderi, Malihe, et al.
Publicado: (2014)

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018)

A review of pregnancy counseling with abnormal fetuses
por: Haqshenas, S.
Publicado: (2021)

An overview of the psychological effects of common contraceptive methods on women
por: Haqshenas, S.
Publicado: (2021)

Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
por: Gerold, Gisa, et al.
Publicado: (2015)

Targeting the Host for New Therapeutic Perspectives in Hepatitis D
por: Turon-Lagot, Vincent, et al.
Publicado: (2020)

Editorial: Heading Against Parasitic Resistance: A Screen for Next Generation Drugs Against Targets of cAMP- or cGMP-regulated Pathways
por: Kaiser, Annette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t2cvjnq79ig86s3bdejch6vks7